MeSH D012223 - vasomotor rhinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Azelastine | Azelastine |  | 2014-05-08 |  |  |
| Azelastine, Fluticasone | Azelastine Fluticasone |  | 2021-02-18 |  |  | |
| Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan |  | 2014-07-15 |  |  | |
| Taro Pharmaceutical | Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan |  | 2017-02-27 |  |  |
| Mylan | Azelastine | Astelin |  | 1996-11-01 |  |  |
| Azelastine | Astepro | 2025-11-22 | 2008-10-15 |  |  | |
| Azelastine, Fluticasone | Dymista | 2023-06-13 | 2012-05-01 |  |  | |
| Azelastine | Optivar |  | 2000-05-22 |  |  | |
| Perrigo | Ibuprofen, Phenylephrine | Ibuprofen Phenylephrine |  | 2014-07-03 |  |  |
| GSK | Ibuprofen, Phenylephrine, Chlorpheniramine | Advil |  | 2011-12-21 |  |  |
| Lupin Research | Phenylephrine, Ketorolac tromethamine | Ketorolac Tromethamine Phenylephrine |  | 2019-07-01 |  |  |
| Sandoz | Azelastine | Azelastine |  | 2012-05-31 |  |  |
| Phenylephrine | Phenylephrine |  | 2019-01-31 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
67%8/12
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use